1921
Volume 98, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Visceral leishmaniasis, a neglected tropical disease, is the third most common opportunistic disease in immunosuppressed patients, such as those affected by the human immunodeficiency virus (HIV)/acquired immune deficiency syndrome. Although the reports have been characterized as /HIV coinfections, the occurrence of a mixed infection by two species in HIV-positive patients is rare. Here, we present an atypical case of disseminated cutaneous leishmaniasis (DCL) in a 26-year-old HIV-positive man. The diagnosis of DCL was established using skin biopsy and histopathology examinations and confirmed by molecular techniques. This is the first case of a /HIV coinfection due to a mixed infection of / in Iran.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.17-0490
2017-11-20
2020-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/98/1/tpmd170490.html?itemId=/content/journals/10.4269/ajtmh.17-0490&mimeType=html&fmt=ahah

References

  1. Mohebali M, 2013. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol 8: 348358.
    [Google Scholar]
  2. Badirzadeh A, Taheri T, Taslimi Y, Abdossamadi Z, Heidari-Kharaji M, Gholami E, Sedaghat B, Niyyati M, Rafati S, 2017. Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites. PLoS Negl Trop Dis 11: e0005774.
    [Google Scholar]
  3. Badirzadeh A, Mohebali M, Asadgol Z, Soong L, Zeinali M, Mokhayeri Y, Shirzadi MR, Spotin A, 2017. The burden of leishmaniasis in Iran, acquired from the global burden of disease during 1990–2010. Asian Pac J Trop Dis 7: 513518.
    [Google Scholar]
  4. Heidari-Kharaji M, Taheri T, Doroud D, Habibzadeh S, Badirzadeh A, Rafati S, 2016. Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against Leishmania in mice model. Parasite Immunol 38: 599608.
    [Google Scholar]
  5. Montakhab-Yeganeh H, Abdossamadi Z, Zahedifard F, Taslimi Y, Badirzadeh A, Saljoughian N, Taheri T, Taghikhani M, Rafati S, 2017. Leishmania tarentolae expressing CXCL-10 as an efficient immunotherapy approach against Leishmania major-infected BALB/c mice. Parasite Immunol 39: e12461.
    [Google Scholar]
  6. Badirzadeh A, Mohebali M, Ghasemian M, Amini H, Zarei Z, Akhoundi B, Hajjaran H, Emdadi D, Molaei S, Kusha A, 2013. Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002–2011: a case series. Pathog Glob Health 107: 194197.
    [Google Scholar]
  7. Jafari S, Hajiabdolbaghi M, Mohebali M, Hajjaran H, Hashemian H, 2010. Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran. East Mediterr Health 16: 340343.
    [Google Scholar]
  8. Pourahmad M, Hooshmand F, Rahiminejad M, 2009. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS). Int J Dermatol 48: 5961.
    [Google Scholar]
  9. Parmentier L et al., 2016. Severe cutaneous leishmaniasis in a human immunodeficiency virus patient coinfected with Leishmania braziliensis and its endosymbiotic virus. Am J Trop Med Hyg 94: 840843.
    [Google Scholar]
  10. Davarpanah M, Rassaei M, 2015. Presentation of AIDS with disseminated cutaneous and visceral leishmaniasis in Iran. Case Rep Infect Dis 2015: 563851.
    [Google Scholar]
  11. Kazemi-Rad E, Mohebali M, Hajjaran H, Rezaei S, Mamishi S, 2008. Diagnosis and characterization of Leishmania species in Giemsa-stained slides by PCR-RFLP. Iran J Public Health 37: 5460.
    [Google Scholar]
  12. Badirzadeh A, Taheri T, Abedi-Astaneh F, Taslimi Y, Abdossamadi Z, Montakhab-Yeganeh H, Aghashahi M, Niyyati M, Rafati S, 2017. Arginase activity of Leishmania isolated from patients with cutaneous leishmaniasis. Parasite Immunol 39: e12454.
    [Google Scholar]
  13. Calvopina M, Aguirre C, Cevallos W, Castillo A, Abbasi I, Warburg A, 2017. Coinfection of Leishmania guyanensis and human immunodeficiency virus-acquired immune deficiency syndrome: report of a case of disseminated cutaneous leishmaniasis in Ecuador. Am J Trop Med Hyg 96: 11511154.
    [Google Scholar]
  14. Shafiei R, Mohebali M, Akhoundi B, Galian MS, Kalantar F, Ashkan S, Fata A, Farash BRH, Ghasemian M, 2014. Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: a preliminary study. Travel Med Infect Dis 12: 173178.
    [Google Scholar]
  15. Calza L, D’antuono A, Marinacci G, Manfredi R, Colangeli V, Passarini B, Orioli R, Varoli O, Chiodo F, 2004. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS. J Am Acad Dermatol 50: 461465.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.17-0490
Loading
/content/journals/10.4269/ajtmh.17-0490
Loading

Data & Media loading...

  • Received : 20 Jun 2017
  • Accepted : 04 Oct 2017
  • Published online : 20 Nov 2017
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error